OptiBiotix Health (LON:OPTI) Shares Down 7.6% – Should You Sell?

OptiBiotix Health Plc (LON:OPTI)’s stock price fell 7.6% during trading on Tuesday . The stock traded as low as GBX 11.10 ($0.15) and last traded at GBX 11.50 ($0.16). 657,423 shares traded hands during trading, an increase of 115% from the average session volume of 306,355 shares. The stock had previously closed at GBX 12.45 ($0.17).

OptiBiotix Health Price Performance

The stock has a market cap of £11.20 million, a P/E ratio of -3.62 and a beta of 1.71. The company has a fifty day moving average of GBX 16.61 and a 200 day moving average of GBX 17.06.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.